二术二陈汤联合八段锦治疗腹型肥胖2型糖尿病患者的临床疗效观察

Clinical effect of Erzhu Erchen decoction combined with Baduanjin decoction on type 2 diabetes mellitus with abdominal obesity

目的观察在为腹型肥胖2型糖尿病(type 2 diabetes mellitus,T2DM)患者实施治疗的过程中应用二术二陈汤联合八段锦所获得的临床疗效.方法此研究对象随机于2020年6月-2022年6月期间在天津市第四中心医院接受腹型肥胖T2DM治疗的患者中选取,共选取的病例数量为76例,所选取病例的分组方法为随机数字表法,共分成两组,实验组(常规治疗+二术二陈汤联合八段锦治疗)与对比组(常规治疗),每组各有38例患者,分析比较不同治疗方案下所取得的治疗效果.结果比较两组患者治疗前中医证候积分、体质量指数以及内脏脂肪面积与饮食行为后可知,P>0.05.治疗后两组患者中医证候积分均有所降低,体质量指数明显下降且内脏脂肪面积有所缩小,与治疗前相比,P<0.05;但是对比组患者治疗前后饮食行为并无明显变化,P>0.05,实验组患者仅在食欲、饮食偏好上出现明显变化,P<0.05.治疗后实验组与对照组患者上述指标差异显著,P<0.05.结论在为腹型肥胖T2DM患者实施治疗的过程中,二术二陈汤联合八段锦在常规治疗方案基础上的应用有助于患者中医证候、体质量指数、内脏脂肪面积等相关指标的改善,规范了患者的饮食行为,是一种理想的治疗方案,值得予以进一步临床推广.

Objective To observe the clinical effect of Erzhu Erchen decoction combined with Baduanjin decoction in the treatment of type 2 diabetes mellitus(T2DM)with abdominal obesity.Methods 76 patients with T2DM with abdominal obesity were randomly selected from the hospital from June 2020 to June 2022,the selected cases were randomly divided into experimental group(routine treatment+Erzhu Erchen decoction combined with Baduanjin)and control group(routine treatment)with 38 cases in each group,to analyze and compare the therapeutic effects of different therapeutic schemes.Results After comparing the TCM symptom score,body mass index,visceral fat area and dietary behavior before treatment,P>0.05.After treatment,the TCM symptom scores,body mass index and the area of visceral fat were decreased in both groups,P<0.05;but there was no significant change in the diet behavior before and after treatment in the control group(P>0.05),while there was only significant change in appetite and diet preference in the experimental group(P<0.05).After treatment,there was significant difference between the two groups(P<0.05).Conclusion The application of Erzhu Erchen decoction combined with Baduanjin in the treatment of abdominal obesity patients with T2DM on the basis of routine treatment scheme is helpful to the improvement of TCM symptoms,body mass index(BMI),visceral fat area and other related indexes,it is an ideal therapeutic scheme to standardize the dietetic behavior of patients and is worth further clinical promotion.